StockData
Rezolute, Inc. logo

Rezolute, Inc. (RZLT) stock

RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$4.25+0.24 (+5.85%)

Close on Nov 18, 2026Market cap $411.07MP/E –Yield –

Rezolute price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Rezolute's price to book ratio was 3.9× on Nov 11, 2026, against 6.0× a year earlier. Over the last 5 years it ranged from 0.3× to 6.0×, with a median of 1.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.9×+2.4
2025Dec 31, 20251.5×−0.9
2024Dec 31, 20242.4×+2.0
2023Dec 29, 20230.4×−0.1
2022Dec 30, 20220.5×−1.4
2021Dec 31, 20211.9×−14.1
2020Dec 31, 202016.1×+16.1
2019Dec 31, 20190.0×−38.6
2018Jul 31, 201838.6×+32.5
2017Dec 29, 20176.1×+1.5
2016Dec 30, 20164.6×−0.7
2015Dec 31, 20155.3×+0.7
2014Dec 31, 20144.5×–

More Rezolute figures

See a number that looks wrong?